CBL and central nervous system cancer: Indeed, Seong et al. [100] demonstrated that c-CBL exon skipping occurred in A172 and C6 glioma cells, as well as in brain tissues of GBM patients, generating two isoforms of the protein which were rapidly degraded by the proteasome.